-
Most Popular
Search Results
240 results for anx
PHVS Stock Earnings: Pharvaris Beats EPS for Q2 2024
PHVS stock results show that Pharvaris beat analyst estimates for earnings per share the second quarter of 2024.
SGRP Stock Earnings: SPAR Group Beats Revenue for Q2 2024
SGRP stock results show that SPAR Group beat on revenue for the second quarter of 2024.
FNCH Stock Earnings: Finch Therapeutics Gr Reported Results for Q2 2024
Finch Therapeutics Gr just reported results for the second quarter of 2024.
HUGE Stock Earnings: FSD Pharma Misses EPS for Q2 2024
HUGE stock results show that FSD Pharma missed analyst estimates for earnings per share the second quarter of 2024.
ACHL Stock Earnings: Achilles Therapeutics Meets EPS for Q2 2024
ACHL stock results show that Achilles Therapeutics met analyst estimates for earnings per share the second quarter of 2024.
VIRX Stock Earnings: Viracta Therapeutics Beats EPS for Q2 2024
VIRX stock results show that Viracta Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
UNCY Stock Earnings: Unicycive Therapeutics Beats EPS for Q2 2024
UNCY stock results show that Unicycive Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
COCP Stock Earnings: Cocrystal Pharma Misses EPS for Q2 2024
COCP stock results show that Cocrystal Pharma missed analyst estimates for earnings per share the second quarter of 2024.
SGMT Stock Earnings: Sagimet Biosciences Beats EPS for Q2 2024
SGMT stock results show that Sagimet Biosciences beat analyst estimates for earnings per share the second quarter of 2024.
RVPH Stock Earnings: Reviva Pharmaceuticals Beats EPS for Q2 2024
RVPH stock results show that Reviva Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.
Why Is Serve Robotics (SERV) Stock Up 20% Today?
Serve Robotics stock is up on Wednesday with heavy trading as SERV investors react to a new partnership with Shake Shack.
DAR Stock Alert: Why Are Shares of Darling Ingredients Soaring Today?
Darling Ingredients stock is up on Tuesday with heavy trading of DAR stock despite a lack of news from the company.
IMNN Stock Earnings: Imunon Beats EPS for Q2 2024
IMNN stock results show that Imunon beat analyst estimates for earnings per share the second quarter of 2024.
NRBO Stock Earnings: NeuroBo Pharmaceuticals Misses EPS for Q2 2024
NRBO stock results show that NeuroBo Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.
SA Stock Earnings: Seabridge Gold Beats EPS for Q2 2024
SA stock results show that Seabridge Gold beat analyst estimates for earnings per share the second quarter of 2024.
PBLA Stock Earnings: Panbela Therapeutics Beats EPS for Q2 2024
PBLA stock results show that Panbela Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
MODD Stock Earnings: Modular Medical Beats EPS for Q1 2025
MODD stock results show that Modular Medical beat analyst estimates for earnings per share the first quarter of 2025.
MBRX Stock Earnings: Moleculin Biotech Beats EPS for Q2 2024
MBRX stock results show that Moleculin Biotech beat analyst estimates for earnings per share the second quarter of 2024.
3 Travel Stocks Poised for a Comeback After Last Week’s Market Meltdown
With rate cuts all but a certainty, the travel stocks trade may have found a second wind. Here are three stocks with compelling charts.
PTON Stock Alert: Why Are Peloton Shares Riding Lower Today
Shares of PTON stock are on the move lower today despite a key partnership the company announced with Google. Here’s what to know.
DA Davidson Just Cut Price Target on CrowdStrike (CRWD) Stock
Shares of CRWD stock are on the move higher today, despite a key downgrade from DA Davidson on concerns around its global outage.
Victoria’s Secret News: What’s Going On With VSCO Stock Today?
Victoria’s Secret stock is up on Wednesday as VSCO investors celebrate a leadership change and strong preliminary earnings.
ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q2 2024
ITRM stock results show that Iterum Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
PYPD Stock Earnings: PolyPid Beats EPS for Q2 2024
PYPD stock results show that PolyPid beat analyst estimates for earnings per share the second quarter of 2024.
8 – 10 of 240 results
